Ambea as an investment
- Growing need
- Market leader
- Quality and competence
- Growth
- Balanced risk
- Cash flow and dividends
The share
Key figures FY 2023
13 312 MSEK
Net sales
1076 MSEK
Adjusted EBITA
6%
Growth
8,1%
Adj EBITA margin
News and press releases
Calendar
- May 32024-05-03 07:00Interim Report First Quarter 2024
- May 152024-05-15 10:00Annual General Meeting
- Jul 42024-07-04 09:002024-07-04 – 2024-08-16 Silent period
- Aug 162024-08-16 07:00Interim Report Second Quarter 2024
Reports
Year-end report January-December 2023
Clear earnings improvement creating future opportunities.
Annual report: Future-proof care
Annual report with quality & sustainability report 2023
IR Contact
Susanne Vogt
No matching results.
